<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2019-04-03-06:00</periodOfReport>

    <notSubjectToSection16>false</notSubjectToSection16>

    <issuer>
        <issuerCik>0001443863</issuerCik>
        <issuerName>BioCorRx Inc.</issuerName>
        <issuerTradingSymbol>BICX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001539788</rptOwnerCik>
            <rptOwnerName>Lucido Louis C.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>2390 EAST ORANGEWOOD AVENUE</rptOwnerStreet1>
            <rptOwnerStreet2>SUITE 575</rptOwnerStreet2>
            <rptOwnerCity>ANAHEIM</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92806</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
            <isOfficer>false</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock, par value $0.001</value>
            </securityTitle>
            <transactionDate>
                <value>2019-04-03-06:00</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>false</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>200000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>15.00</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>245411</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>Louis and Carolyn Lucido CRT LLC</value>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">These shares were issued to the Louis and Carolyn Lucido CRT LLC (&quot;Lucido LLC&quot;) pursuant to a subscription and royalty agreement by and between BioCorRx Inc. and the Lucido LLC dated March 27, 2019, fully executed on March 28, 2019, and paid for on April 3, 2019. The Reporting Person may be deemed to have investment power over the Lucido LLC.</footnote>
        <footnote id="F2">Of the 245,411 shares held following this transaction, the Reporting Person holds 45,411 shares directly and 200,000 shares indirectly via his control of the Lucido LLC.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Louis Lucido</signatureName>
        <signatureDate>2019-04-04-06:00</signatureDate>
    </ownerSignature>
</ownershipDocument>
